
    
      This two-part study will assess, in healthy volunteers, under fasted conditions, and in a
      sequential manner, the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD)
      of single- and multiple-ascending doses of CTP-543.
    
  